GC
PETS icon

Guggenheim Capital’s PetMed Express PETS Stock Holding History

Guggenheim Capital’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,726
Closed -$603K – 1899
2023
Q2 		$603K Buy
+43,726
New +$656K ﹤0.01% 1382
2021
Q3 		– Sell
-6,374
Closed -$203K – 2203
2021
Q2 		$203K Buy
6,374
+64
+1% +$2.03K ﹤0.01% 2133
2021
Q1 		$222K Sell
6,310
-5,930
-48% -$206K ﹤0.01% 2052
2020
Q4 		$392K Buy
+12,240
New +$377K ﹤0.01% 1738
2018
Q4 		– Sell
-21,649
Closed -$715K – 2323
2018
Q3 		$715K Sell
21,649
-10,356
-32% -$387K ﹤0.01% 1787
2018
Q2 		$1.41M Sell
32,005
-46,520
-59% -$1.8M 0.01% 1445
2018
Q1 		$3.28M Sell
78,525
-13,913
-15% -$642K 0.01% 1289
2017
Q4 		$4.21M Buy
92,438
+20,238
+28% +$797K 0.01% 1132
2017
Q3 		$2.39M Buy
72,200
+4,491
+7% +$183K 0.01% 1534
2017
Q2 		$2.75M Buy
67,709
+4,168
+7% +$129K 0.01% 1396
2017
Q1 		$1.28M Buy
63,541
+12,376
+24% +$262K ﹤0.01% 1967
2016
Q4 		$1.18M Sell
51,165
-365
-0.7% -$7.82K ﹤0.01% 2056
2016
Q3 		$1.04M Sell
51,530
-8,220
-14% -$166K ﹤0.01% 2054
2016
Q2 		$1.12M Sell
59,750
-26,700
-31% -$491K ﹤0.01% 1975
2016
Q1 		$1.55M Sell
86,450
-22,132
-20% -$379K ﹤0.01% 1753
2015
Q4 		$1.86M Sell
108,582
-18,823
-15% -$316K 0.01% 1666
2015
Q3 		$2.05M Sell
127,405
-12,006
-9% -$201K 0.01% 1570
2015
Q2 		$2.41M Sell
139,411
-923
-0.7% -$15.5K 0.01% 1609
2015
Q1 		$2.32M Buy
140,334
+1,574
+1% +$24.4K 0.01% 1649
2014
Q4 		$1.99M Sell
138,760
-6,800
-5% -$91.6K 0.01% 1739
2014
Q3 		$1.98M Sell
145,560
-3,144
-2% -$43.8K ﹤0.01% 1771
2014
Q2 		$2M Buy
148,704
+8,645
+6% +$114K 0.01% 1828
2014
Q1 		$1.88M Buy
140,059
+3,100
+2% +$43K 0.01% 1840
2013
Q4 		$2.28M Buy
136,959
+3,217
+2% +$50.2K 0.01% 1668
2013
Q3 		$2.18M Buy
133,742
+16,582
+14% +$259K 0.01% 1560
2013
Q2 		$1.48M Buy
+117,160
New +$1.53M 0.01% 1736

Other funds holding PETS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Guggenheim Capital's PETS Position: Q3 2023 in Review

Guggenheim Capital sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 43,726 shares — an estimated $603K sold.

Guggenheim Capital first reported a position in PETS in Q2 2013 and held it in 26 quarters. The position peaked at $4.21M in Q4 2017. 138 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

  • Guggenheim Capital reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
  • Guggenheim Capital sold 43,726 PetMed Express shares in Q3 2023, an estimated $603K.
  • Guggenheim Capital first reported a position in PetMed Express in Q2 2013 and held it in 26 quarters.
  • Guggenheim Capital's PetMed Express position peaked at $4.21M in Q4 2017.
  • 138 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.